Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Fast Track Initiative

Fast Track Initiative

A venture capital firm in Tokyo that focuses on life sciences and healthcare services.

Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, Japan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.

Timeline

2004
Founded

Invested in

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

References

Golden logo
By using this site, you agree to our Terms & Conditions.